Latest News

 Filter by Provider

This company is helping resolve a key strategic rare earth supply chain problem for the U.S.

KORE stated that Searchlight and Abry will acquire all shares of the company’s issued and outstanding common stock that they currently don’t own in an all-cash transaction valued at nearly $726 million.

Neurogene stock jumps after FDA grants Breakthrough Therapy status to NGN-401 for Rett syndrome treatment.

Shares of Micron are up more than 250% since the summer.

While Chipotle Mexican Grill has underperformed relative to its sector over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Check out the companies making headlines this week:

The company priced a $48 million registered direct offering to a single institutional investor.

Microsoft and Meta Platforms are trading at attractive levels.

Welltower is a much healthier REIT.

Salesforce Inc. (NYSE: CRM) shares edged lower in Friday's premarket trading, despite a standout quarterly performance.

Here's what the benchmarks look like for ideal retirement savings at age 50 -- and what to do if you're behind.

Sherwin-Williams has underperformed other basic materials stocks over the past year, yet analysts remain moderately optimistic about the stock’s future outlook.

The company said that the U.S. Food and Drug Administration granted a key designation for its investigational gene therapy targeting Rett syndrome.

If you're going to make a change, do so carefully.

Cadence Design has outperformed the Dow over the past year, and analysts remain highly bullish on its future outlook.

Rocket Lab Corp (NASDAQ: RKLB) shares fell in premarket trading due to a delay in its first Neutron rocket launch to late 2026.

A lot of people keep too much cash in their checking account. Here's the simple rule of thumb that protects you from overdrafts without costing you interest.

Analysts think these two discount retailers could benefit from the new tariff regime.